Corrigendum: Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?

Joseph D. Wilson,Ester M. Hammond,Geoff S. Higgins,Kristoffer Petersson

DOI: https://doi.org/10.3389/fonc.2020.00210

IF: 4.7

2020-02-25

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2019.01563.].

oncology

What problem does this paper attempt to address?

Corrigendum: Low-Dose Total Body Irradiation Can Enhance Systemic Immune Related Response Induced by Hypo-Fractionated Radiation

Jing Liu,Jie Zhou,Min Wu,ChuanFei Hu,Juan Yang,Dong Li,Peng Wu,Yue Chen,Ping Chen,Sheng Lin,YongXia Cui,ShaoZhi Fu,JingBo Wu

DOI: https://doi.org/10.3389/fimmu.2021.745787

IF: 7.3

2021-09-03

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2019.00317.].

immunology
Two-stage Oxygen Delivery for Enhanced Radiotherapy by Perfluorocarbon Nanoparticles: Erratum

Zaigang Zhou,Baoli Zhang,Haoran Wang,Ahu Yuan,Yiqiao Hu,Jinhui Wu

DOI: https://doi.org/10.7150/thno.42420

IF: 11.6

2020-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.27598.].
Erratum: Addition and Correction to "High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles"

Kin Man Au,Rod Balhorn,Monique C Balhorn,Steven I Park,Andrew Z Wang

DOI: https://doi.org/10.1021/acscentsci.4c00703

2024-05-08

Abstract:[This corrects the article DOI: 10.1021/acscentsci.8b00746.].
Corrigendum: Radioactivity and Space Range of Ultra-Low-activity for in Vivo Off-Line PET Verification of Proton and Carbon Ion Beam-a Phantom Study.

Fuquan Zhang,Junyu Zhang,Yan Lu,Yixiangzi Sheng,Yun Sun,Jiangang Zhang,Jingyi Cheng,Rong Zhou

DOI: https://doi.org/10.3389/fpubh.2024.1505079

IF: 5.2

2024-01-01

Frontiers in Public Health

Abstract:[This corrects the article DOI: 10.3389/fpubh.2021.771017.].
Erratum: Overcoming immune resistance with radiation therapy in prostate cancer

DOI: https://doi.org/10.3389/fimmu.2023.1185185

IF: 7.3

2023-03-23

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.859785.].

immunology
Corrigendum: Rational design of a Gd(III)–Cu(II) nanobooster for chemodynamic therapy against cancer cells

Xin-Ya Shi,Ting-Xiao Shen,Ao-Lin Zhang,Li-Tao Tan,Wen-Chang Shen,Hai-Jiang Zhong,Shun-Lin Zhang,Yu-Lan Gu,Lei Shen

DOI: https://doi.org/10.3389/fchem.2022.1075376

IF: 5.5

2022-11-23

Frontiers in Chemistry

Abstract:[This corrects the article DOI: 10.3389/fchem.2022.856495.].

chemistry, multidisciplinary
Erratum: Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics [Corrigendum]

DOI: https://doi.org/10.2147/IJN.S500182

2024-10-14

Abstract:[This corrects the article DOI: 10.2147/IJN.S448556.].
Erratum: Short- and long-term effects of radiation exposure at low dose and low dose rate in normal human VH10 fibroblasts

Frontiers Production Office

DOI: https://doi.org/10.3389/fpubh.2024.1400355

IF: 5.2

2024-04-11

Frontiers in Public Health

Abstract:This article is an erratum on: Short- and long-term effects of radiation exposure at low dose and low dose rate in normal human VH10 fibroblasts

public, environmental & occupational health
Corrigendum: Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2S,4R)-4-18F-Fluoroglutamine

Senthil Palani,Maxwell W. G. Miner,Jenni Virta,Heidi Liljenbäck,Olli Eskola,Tiit Örd,Aarthi Ravindran,Minna U. Kaikkonen,Juhani Knuuti,Xiang-Guo Li,Antti Saraste,Anne Roivainen

DOI: https://doi.org/10.3389/fimmu.2022.902544

IF: 7.3

2022-04-12

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.821423.].

immunology
Correction for the Research Article: "High-flux soft x-ray harmonic generation from ionization-shaped few-cycle laser pulses" by A. S. Johnson, D. R. Austin, D. A. Wood, C. Brahms, A. Gregory, K. B. Holzner, S. Jarosch, E. W. Larsen, S. Parker, C. S. Strüber, P. Ye, J. W. G. Tisch and J. P. Marangos

DOI: https://doi.org/10.1126/sciadv.abc5176

2020-05-13

Abstract:[This corrects the article DOI: 10.1126/sciadv.aar3761.].
FLASH radiotherapy: ultra-high dose rates to spare healthy tissue

R M de Kruijff

DOI: https://doi.org/10.1080/09553002.2020.1704912

Abstract:A recent addition to the treatment options in external beam therapy, so-called FLASH radiotherapy, shows remarkable healthy-tissue-sparing properties in a number of pre-clinical studies without impacting the overall treatment efficacy. Its potential in clinical applications is attracting a great deal of interest in the medical community. The use of ultra-high dose rates at extremely short irradiation times has been shown to significantly enhance the differential effects between normal and tumor tissue. This makes it possible to increase treatment doses without further harming the surrounding healthy tissue. While most studies to date have focused on the use of electron beams, X-ray and proton FLASH radiotherapy have also shown beneficial effects, although for these latter two the results still need to be independently confirmed. Furthermore, the mechanisms underlying the biological effects remain to be elucidated. Very recently, the FLASH effect has been demonstrated in the first human patient, with promising results, supporting further clinical studies. This review will present an overview of the investigations into FLASH radiotherapy to date.
Correction: Catalase-like Metal–organic Framework Nanoparticles to Enhance Radiotherapy in Hypoxic Cancer and Prevent Cancer Recurrence

Yuanyuan Chen,Hui Zhong,Jianbo Wang,Xiuyan Wan,Yanhua Li,Wei Pan,Na Li,Bo Tang

DOI: https://doi.org/10.1039/d0sc90108c

IF: 8.4

2020-01-01

Chemical Science

Abstract:Correction for ‘Catalase-like metal–organic framework nanoparticles to enhance radiotherapy in hypoxic cancer and prevent cancer recurrence’ by Yuanyuan Chen et al., Chem. Sci., 2019, 10, 5773–5778, DOI: 10.1039/C9SC00747D.
The FLASH effect—an evaluation of preclinical studies of ultra-high dose rate radiotherapy

Josie May McGarrigle,Kenneth Richard Long,Yolanda Prezado

DOI: https://doi.org/10.3389/fonc.2024.1340190

IF: 4.7

2024-04-23

Frontiers in Oncology

Abstract:FLASH radiotherapy (FLASH-RT) is a novel radiotherapy approach based on the use of ultra-high dose radiation to treat malignant cells. Although tumours can be reduced or eradicated using radiotherapy, toxicities induced by radiation can compromise healthy tissues. The FLASH effect is the observation that treatment delivered at an ultra-high dose rate is able to reduce adverse toxicities present at conventional dose rates. While this novel technique may provide a turning point for clinical practice, the exact mechanisms underlying the causes or influences of the FLASH effect are not fully understood. The study presented here uses data collected from 41 experimental investigations (published before March 2024) of the FLASH effect. Searchable databases were constructed to contain the outcomes of the various experiments in addition to values of beam parameters that may have a bearing on the FLASH effect. An in-depth review of the impact of the key beam parameters on the results of the experiments was carried out. Correlations between parameter values and experimental outcomes were studied. Pulse Dose Rate had positive correlations with almost all end points, suggesting viability of FLASH-RT as a new modality of radiotherapy. The collective results of this systematic review study suggest that beam parameter qualities from both FLASH and conventional radiotherapy can be valuable for tissue sparing and effective tumour treatment.

oncology
Correction: A highly X-ray sensitive iridium prodrug for visualized tumor radiochemotherapy

Zhennan Zhao,Pan Gao,Li Ma,Tianfeng Chen

DOI: https://doi.org/10.1039/d1sc90029c

IF: 8.4

2021-01-01

Chemical Science

Abstract:Correction for ’A highly X-ray sensitive iridium prodrug for visualized tumor radiochemotherapy’ by Zhennan Zhao et al. , Chem. Sci. , 2020, 11 , 3780–3789, DOI: 10.1039/D0SC00862A

chemistry, multidisciplinary
Erratum: "Interferon-γ liposome: a new system to improve drug delivery in the treatment of lung cancer". Maysa Alhawamdeh, Mohammad Isreb, Abid Aziz, Badie K. Jacob, Diana Anderson and Mojgan Najafzadeh. ERJ Open Res 2021; 7: 00555-2020

DOI: https://doi.org/10.1183/23120541.50555-2020

2021-12-06

Abstract:[This corrects the article DOI: 10.1183/23120541.00555-2020.].
Erratum: Yttrium-90 Radioembolization Dosimetry: What Trainees Need to Know

Alexander Villalobos,Mohamed Soliman,Bill Majdalany,David Schuster,James Galt,Zachary Bercu,Nima Kokabi,Mohamed M. Soliman,Bill S. Majdalany,David M. Schuster,Zachary L. Bercu

DOI: https://doi.org/10.1055/s-0041-1722877

2020-12-01

Seminars in Interventional Radiology

Abstract:[This corrects the article DOI: 10.1055/s-0040-1720954.].

radiology, nuclear medicine & medical imaging
Correction: Mazzini et al. Anatomical and Functional Outcomes after Endoresection and Adjuvant Ruthenium Brachytherapy for Uveal Melanoma: A Single-Center Experience. Life 2023, 13, 902

Cinzia Mazzini,Giulio Vicini,Laura Di Leo,Daniela Massi,Stanislao Rizzo,Fabrizio Giansanti

DOI: https://doi.org/10.3390/life14020162

2024-01-23

Life

Abstract:Life, Vol. 14, Pages 162: Correction: Mazzini et al. Anatomical and Functional Outcomes after Endoresection and Adjuvant Ruthenium Brachytherapy for Uveal Melanoma: A Single-Center Experience. Life 2023, 13, 902 Life doi: 10.3390/life14020162 Authors: Cinzia Mazzini Giulio Vicini Laura Di Leo Daniela Massi Stanislao Rizzo Fabrizio Giansanti There was an error in the original publication [...]

biology
Corrigendum to "Neurocognitive dysfunction and predictors in non-CNS cancer patients: Rationale and methods for the neuro-oncology research at a South African academic hospital" [Heliyon 10(1) (January 2024) e23007]

Antonio G Lentoor,Tiro Bright Motsamai

DOI: https://doi.org/10.1016/j.heliyon.2024.e32320

IF: 3.776

2024-06-01

Heliyon

Abstract:[This corrects the article DOI: 10.1016/j.heliyon.2023.e23007.].
Erratum: Protocol of the HISTOTHERM study: assessing the response to hyperthermia and hypofractionated radiotherapy in recurrent breast cancer

Frontiers Production Office

DOI: https://doi.org/10.3389/fonc.2024.1414294

IF: 4.7

2024-04-20

Frontiers in Oncology

Abstract:This article is an erratum on: Protocol of the HISTOTHERM study: assessing the response to hyperthermia and hypofractionated radiotherapy in recurrent breast cancer

oncology
Correction Notice: Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use

DOI: https://doi.org/10.1097/HS9.0000000000000987

2023-10-31

HemaSphere

Abstract:[This corrects the article DOI: 10.1097/HS9.0000000000000907.].

Corrigendum: Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?

Corrigendum: Low-Dose Total Body Irradiation Can Enhance Systemic Immune Related Response Induced by Hypo-Fractionated Radiation

Two-stage Oxygen Delivery for Enhanced Radiotherapy by Perfluorocarbon Nanoparticles: Erratum

Erratum: Addition and Correction to "High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles"

Corrigendum: Radioactivity and Space Range of Ultra-Low-activity for in Vivo Off-Line PET Verification of Proton and Carbon Ion Beam-a Phantom Study.

Erratum: Overcoming immune resistance with radiation therapy in prostate cancer

Corrigendum: Rational design of a Gd(III)–Cu(II) nanobooster for chemodynamic therapy against cancer cells

Erratum: Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics [Corrigendum]

Erratum: Short- and long-term effects of radiation exposure at low dose and low dose rate in normal human VH10 fibroblasts

Corrigendum: Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2S,4R)-4-18F-Fluoroglutamine

FLASH radiotherapy: ultra-high dose rates to spare healthy tissue

Correction: Catalase-like Metal–organic Framework Nanoparticles to Enhance Radiotherapy in Hypoxic Cancer and Prevent Cancer Recurrence

The FLASH effect—an evaluation of preclinical studies of ultra-high dose rate radiotherapy

Correction: A highly X-ray sensitive iridium prodrug for visualized tumor radiochemotherapy

Erratum: "Interferon-γ liposome: a new system to improve drug delivery in the treatment of lung cancer". Maysa Alhawamdeh, Mohammad Isreb, Abid Aziz, Badie K. Jacob, Diana Anderson and Mojgan Najafzadeh. ERJ Open Res 2021; 7: 00555-2020

Erratum: Yttrium-90 Radioembolization Dosimetry: What Trainees Need to Know

Correction: Mazzini et al. Anatomical and Functional Outcomes after Endoresection and Adjuvant Ruthenium Brachytherapy for Uveal Melanoma: A Single-Center Experience. Life 2023, 13, 902

Corrigendum to "Neurocognitive dysfunction and predictors in non-CNS cancer patients: Rationale and methods for the neuro-oncology research at a South African academic hospital" [Heliyon 10(1) (January 2024) e23007]

Erratum: Protocol of the HISTOTHERM study: assessing the response to hyperthermia and hypofractionated radiotherapy in recurrent breast cancer

Correction Notice: Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use